[Federal Register Volume 75, Number 128 (Tuesday, July 6, 2010)]
[Notices]
[Pages 38819-38821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-16101]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 75 FR 22821-29, dated April 30, 2010) is
amended to reflect the reorganization of the Division of Blood
Disorders within the National Center on Birth Defects and Developmental
Disabilities, Office of Noncommunicable Diseases, Injury and
Environmental Health, Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and function statement for the
Office of the Director (CUBD1) and insert the following.
Office of the Director (CUBD1). (1) Provides leadership and
guidance on strategic planning and implementation,
[[Page 38820]]
program priority setting, and policy development, to advance the
mission of the Division of Blood Disorders, NCBDDD and CDC; (2)
develops goals, objectives, and budget; monitors progress and
allocation of resources, and reports accomplishments, future
directions, and resource requirements; (3) facilitates scientific,
policy and program collaboration among divisions and centers, and
between CDC and other Federal/non-Federal partners; (4) promotes
advancement of science throughout the division, supports program
evaluation, and ensures that research meets the highest standards in
the field; (5) provides medical expertise and consultation to planning,
projects, policies and program activities; (6) advises the Office of
the Director of NCBDDD on matters relating to prevention of
complications due to blood disorders and coordinates division responses
to requests for technical assistance or information on activities
supported by the division; (7) develops and produces communications
tools and public affairs strategies to meet the needs of division
programs and mission; (8) represents the division at official
professional and scientific meetings, both within and outside of CDC;
(9) applies evaluation and prevention effectiveness functions in the
assessment of blood disorder programs, projects and activities; (10)
develops, implements and evaluates long term plans for surveillance,
research and prevention activities pertaining to blood disorders; and
(11) drafts and disseminates reports of future plans and needs to
inform policy.
After the Office of the Director (CUBD1) Division of Blood
Disorders, National Center on Birth Defects and Developmental
Disabilities, Office of Noncommunicable Diseases, Injury and
Environmental Health, Centers for Disease Control and Prevention,
insert the following:
Epidemiology and Surveillance Branch (CUBDB). (1) Provides
scientific leadership in the design and implementation of monitoring
systems as well as designs and conducts epidemiologic and genetic
research to identify causes, risk factors and complications of blood
disorders in affected populations; (2) designs and manages surveillance
systems to evaluate the incidence, morbidity, and mortality associated
with blood diseases and disorders; (3) plans, develops and coordinates
special surveys and populations studies to monitor and assess the
complications of blood disorders; (4) designs and implements studies
using surveillance data to identify risk factors for the complications
of blood disorders, and evaluates the effectiveness of the prevention
activities; (5) provides epidemiologic and medical consultation and
technical assistance, including epidemic aids to State and local health
departments, other governmental agencies, and other public and private
institutions in the investigation of blood disorders and related
complications; (6) designs and implements studies to evaluate the
effectiveness of implemented prevention strategies in the treatment
centers; (7) works closely with internal and external organizations in
applying prevalence and incidence data to target and evaluate programs
to prevent the complications of blood diseases and chronic hereditary
disorders; (8) publishes findings and advances arising out of
surveillance and epidemiologic research to the scientific and public
health communities; (9) provides training services to States,
localities, and other countries in investigation, diagnosis,
prevention, and control of blood diseases and chronic hereditary
disorders; (10) assists in designing, implementing, and evaluating
prevention and counseling programs for persons and their families with
chronic blood diseases and selected chronic hereditary disorders; (11)
designs, implements and coordinates the prevention and surveillance
activities of specialized Federally funded prevention centers organized
to prevent the complications of blood diseases and chronic hereditary
disorders; (12) conducts and supports both qualitative and quantitative
research to expand the knowledge base related to blood disorders across
the lifespan; and (13) collaborates with laboratory research branch and
prevention research branch and incorporates the findings of these
branches' activities which leads to prevention of complications of
blood disorders.
Laboratory Research Branch (CUBDC). (1) Identifies new genetic
markers of risk factors and clotting defects for affected groups; (2)
provides reference laboratory diagnosis for multi-site epidemiologic
and surveillance studies; (3) develops techniques and interpretation
methods to improve molecular and coagulation diagnosis; (4) provides
diagnostic support for epidemiologic studies and epidemic aids on
emerging blood disorders and chronic hereditary disorders; (5)
determines the mechanisms of pathogenesis and complications of blood
disorders and chronic hereditary disorders; (6) conducts research and
provides reference services on diagnostic techniques for blood
disorders and chronic hereditary disorders; (7) conducts research to
improve laboratory methodologies and materials; (8) where appropriate,
maintains the national reference laboratory for blood disorders and
chronic hereditary disorders; (9) works closely with entities and
organizations within the agency and organizations external to the
agency to provide laboratory services in support of projects whose
primary aim is to prevent and reduce complications associated with
blood disorders and chronic hereditary disorders; and (10) publishes
findings and advances arising out of surveillance and epidemiologic
research to the scientific and public health communities.
Prevention Research and Informatics Branch (CUBDD). (1) Performs
health services research; (2) translates and evaluates the latest
scientific advances from surveillance, epidemiology and laboratory
support into enhanced delivery of care, prevention services, and
information for affected populations; (3) develops, implements,
evaluates and disseminates education and communication interventions
that seek to identify and educate affected populations, providers and
the public on health risks, protective factors and measures of
effectiveness of health promotion activities and prevention of
complications related to blood disorders; (4) collects, analyzes and
prepares reports to document the prevalence and incidence of blood
disorders and related complications and provides this information to
affected populations through reports, publications, and public access
data sets; (5) supports public health analysis to include facilitating
data collection, data management, data manipulation, analysis, project
reporting and presentation; (6) coordinates partnership activities; (7)
assesses informatics needs and develops strategies to ensure accurate
collection of data related to blood disorders and the division's
activities; (8) conducts applied research to develop, evaluate, improve
and standardize public information systems and educational modules
which support the prevention of complications from blood disorders; (9)
develops and maintains systems for collection, processing, validation,
storage and dissemination of the highest quality information to study
and monitor blood disorders; (10) disseminates findings and advances
arising out of surveillance and epidemiologic research to the
scientific and public health communities, and the
[[Page 38821]]
general public; (11) collaborates with and provides technical
assistance, consultation, and training to local, State, Federal, and
international agencies, universities and governmental and non-
governmental organizations on blood disorders and health related
issues; (12) collaborates with local, State, Federal, and international
agencies, and appropriate governmental and non-governmental
organizations to develop, review, and implement policies that advance
the health of people with blood disorders across the lifespan; (13)
collaborates with funded non-governmental agencies to disseminate best
practices, identify areas of need, facilitate development and
distribution of educational materials, and provide informational
resources to States and affected populations and their caregivers; and
(14) develops informatics related trainings and communicates
informatics changes to external partners.
Dated: June 21, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-16101 Filed 7-2-10; 8:45 am]
BILLING CODE 4160-18-M